BG Medicine, Inc. (BGMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | -1.52 Million USD | -31.13% |
| 2014 | -1.16 Million USD | -166.13% |
| 2013 | -437 Thousand USD | 85.08% |
| 2012 | -2.92 Million USD | 87.73% |
| 2011 | -23.87 Million USD | -925.08% |
| 2010 | -2.32 Million USD | 67.16% |
| 2009 | -7.09 Million USD | 59.68% |
| 2008 | -17.58 Million USD | 0.0% |
| 2006 | 300 Thousand USD | -92.39% |
| 2005 | 3.94 Million USD | -33.74% |
| 2004 | 5.94 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2015 FY | -1.52 Million USD | -31.13% |
| 2015 Q1 | 244 Thousand USD | 120.98% |
| 2015 Q2 | 1.49 Million USD | 513.11% |
| 2015 Q3 | -2.64 Million USD | -276.6% |
| 2015 Q4 | -1.52 Million USD | 42.28% |
| 2014 Q2 | -4.38 Million USD | -321.34% |
| 2014 Q3 | -2.25 Million USD | 48.62% |
| 2014 Q4 | -1.16 Million USD | 48.4% |
| 2014 FY | -1.16 Million USD | -166.13% |
| 2014 Q1 | 1.98 Million USD | 553.55% |
| 2013 Q2 | -7.12 Million USD | 38.34% |
| 2013 FY | -437 Thousand USD | 85.08% |
| 2013 Q4 | -437 Thousand USD | 85.25% |
| 2013 Q3 | -2.96 Million USD | 58.41% |
| 2013 Q1 | -11.55 Million USD | -294.5% |
| 2012 Q4 | -2.92 Million USD | 62.2% |
| 2012 FY | -2.92 Million USD | 87.73% |
| 2012 Q1 | -18.18 Million USD | 23.84% |
| 2012 Q3 | -7.74 Million USD | 40.44% |
| 2012 Q2 | -13.01 Million USD | 28.44% |
| 2011 FY | -23.87 Million USD | -925.08% |
| 2011 Q4 | -23.87 Million USD | -82.23% |
| 2011 Q3 | -13.1 Million USD | 28.79% |
| 2011 Q2 | -18.39 Million USD | 48.35% |
| 2011 Q1 | -35.61 Million USD | -1429.37% |
| 2010 Q3 | -2.46 Million USD | 17.13% |
| 2010 Q2 | -2.97 Million USD | 0.0% |
| 2010 Q4 | -2.32 Million USD | 5.59% |
| 2010 FY | -2.32 Million USD | 67.16% |
| 2009 Q4 | -7.09 Million USD | 0.0% |
| 2009 FY | -7.09 Million USD | 59.68% |
| 2008 FY | -17.58 Million USD | 0.0% |
| 2007 Q3 | 772 Thousand USD | 133.45% |
| 2007 Q2 | -2.3 Million USD | -359.33% |
| 2007 Q1 | 890 Thousand USD | 196.67% |
| 2006 Q4 | 300 Thousand USD | 0.0% |
| 2006 FY | 300 Thousand USD | -92.39% |
| 2005 FY | 3.94 Million USD | -33.74% |
| 2004 FY | 5.94 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 100.0% |
| Ansell Limited | -54.99 Million USD | 100.0% |
| Ansell Limited | -55.1 Million USD | 100.0% |
| Biotage AB (publ) | -36.49 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -105.1 Thousand USD | 100.0% |
| Psykey, Inc. | 634.59 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| Encision Inc. | 1.29 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
| Innovative MedTech Inc. | 1.76 Million USD | 100.0% |
| LifePoint, Inc. | -3.26 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -43.3 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -1.03 Million USD | 100.0% |
| SmileDirectClub, Inc. | 778.67 Million USD | 100.0% |
| Sector 10, Inc. | 163 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.0% |
| SheerVision, Inc. | 57.34 Thousand USD | 100.0% |
| United Health Products, Inc. | 660.56 Thousand USD | 100.0% |
| Vasamed, Inc. | 22.12 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 100.0% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 100.0% |